Sang Kun Lee Selected Research

Levetiracetam (Keppra)

1/2019	A randomized, open-label, multicenter comparative trial of levetiracetam and topiramate as adjunctive treatment for patients with focal epilepsy in Korea.
10/2018	Increased adverse events associated with antiepileptic drugs in anti-leucine-rich glioma-inactivated protein 1 encephalitis.
7/2018	A Psychiatric Side Effect of Levetiracetam Can Mimic a Relapse of Anti-Leucine-Rich Glioma Inactivated 1 Encephalitis.
1/2018	HLA-A*11:01 is associated with levetiracetam-induced psychiatric adverse events.
3/2017	Three-Year Retention Rates of Levetiracetam, Topiramate, and Oxcarbazepine: A Retrospective Hospital-Based Study.
1/2017	Population pharmacokinetics and dose-response relationship of levetiracetam in adult patients with epilepsy.
1/2017	Comparison of levetiracetam and oxcarbazepine monotherapy among Korean patients with newly diagnosed focal epilepsy: A long-term, randomized, open-label trial.
4/2016	Factors influencing topiramate clearance in adult patients with epilepsy: A population pharmacokinetic analysis.
1/2014	Unique behavioral characteristics and microRNA signatures in a drug resistant epilepsy model.
9/2013	The long-term efficacy and safety of levetiracetam in a tertiary epilepsy centre.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sang Kun Lee Research Topics

Disease

44	Epilepsy (Aura) 01/2022 - 03/2002
33	Seizures (Absence Seizure) 01/2022 - 06/2004
19	Encephalitis (Encephalitis, Rasmussen) 08/2021 - 12/2013
13	Autoimmune Diseases of the Nervous System 10/2022 - 12/2014
12	Stroke (Strokes) 01/2018 - 03/2008
11	Status Epilepticus (Complex Partial Status Epilepticus) 10/2022 - 06/2004
8	Partial Epilepsies (Epilepsy, Partial) 12/2021 - 07/2007
8	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 08/2021 - 04/2014
8	Inflammation (Inflammations) 05/2018 - 03/2008
7	Glioma (Gliomas) 11/2018 - 12/2013
6	Temporal Lobe Epilepsy 03/2021 - 03/2002
6	Brain Diseases (Brain Disorder) 04/2016 - 12/2012
5	Neoplasms (Cancer) 01/2022 - 12/2009
5	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 01/2012
5	Cerebral Hemorrhage 01/2017 - 01/2010
5	Nervous System Diseases (Neurological Disorders) 01/2016 - 11/2008
5	Drug Resistant Epilepsy 06/2015 - 07/2006
5	Ischemia 12/2010 - 01/2007
4	Drug-Related Side Effects and Adverse Reactions 12/2021 - 10/2015
4	Meningitis 01/2021 - 04/2017
4	Exanthema (Rash) 01/2021 - 09/2015
4	Brain Ischemia (Cerebral Ischemia) 06/2013 - 05/2008
3	Atrophy 10/2022 - 12/2010
3	Bacterial Meningitis 01/2022 - 09/2019
3	Cognitive Dysfunction 01/2021 - 02/2016
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2017
3	Pneumonia (Pneumonitis) 01/2021 - 10/2018
3	Huntington Disease (Huntington's Disease) 01/2017 - 11/2009
3	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2016 - 12/2013
3	Ischemic Stroke 01/2016 - 01/2009
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 10/2018
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2021
2	Infections 01/2022 - 12/2018
2	REM Sleep Behavior Disorder 04/2020 - 04/2019
2	Dizziness (Lightheadedness) 01/2020 - 10/2013
2	Orthostatic Hypotension (Postural Hypotension) 01/2020 - 09/2017
2	Nausea 01/2020 - 10/2013
2	Postural Orthostatic Tachycardia Syndrome 05/2019 - 01/2018
2	Epileptic Syndromes 01/2019 - 05/2014
2	Disease Progression 01/2019 - 10/2014
2	Hyponatremia 10/2018 - 03/2014
2	Orthostatic Intolerance 09/2018 - 01/2018
2	Intracranial Aneurysm (Cerebral Aneurysm) 01/2018 - 05/2016
2	Generalized Epilepsy 01/2018 - 01/2017
2	Migraine Disorders (Migraine) 06/2017 - 07/2006
2	Infarction (Infarctions) 03/2017 - 01/2009
2	Hypertension (High Blood Pressure) 03/2017 - 01/2011

Drug/Important Bio-Agent (IBA)

21	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 01/2008
11	Pilocarpine (Ocusert)FDA LinkGeneric 11/2021 - 06/2004
11	Levetiracetam (Keppra)FDA LinkGeneric 01/2019 - 07/2007
10	Pharmaceutical PreparationsIBA 03/2021 - 07/2006
10	AntibodiesIBA 01/2021 - 04/2014
9	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 08/2021 - 01/2009
9	Oxcarbazepine (Trileptal)FDA LinkGeneric 01/2021 - 01/2012
8	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2011
7	Leucine (L-Leucine)FDA Link 11/2018 - 12/2013
6	Rituximab (Mabthera)FDA Link 01/2021 - 01/2016
5	Proteins (Proteins, Gene)FDA Link 11/2021 - 12/2013
5	Lamotrigine (Lamictal)FDA LinkGeneric 01/2021 - 09/2015
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2019
4	perampanelIBA 12/2021 - 01/2019
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2016
4	CenobamateIBA 01/2021 - 01/2020
4	Topiramate (Topamax)FDA LinkGeneric 01/2019 - 01/2013
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 01/2018
3	Interleukin-2 (IL2)IBA 01/2022 - 01/2016
3	CytokinesIBA 01/2022 - 09/2011
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 03/2008
3	tocilizumab (atlizumab)FDA Link 01/2021 - 10/2016
3	Indicators and Reagents (Reagents)IBA 01/2018 - 08/2010
3	AutoantibodiesIBA 02/2017 - 12/2013
3	Valproic Acid (Depakote)FDA LinkGeneric 04/2016 - 01/2013
3	Kainic Acid (Kainate)IBA 08/2015 - 11/2012
3	Erythropoietin FDA Link 01/2012 - 10/2008
3	NitritesIBA 08/2011 - 01/2009
3	LithiumIBA 03/2009 - 10/2004
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2012
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2022 - 11/2018
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022 - 11/2018
2	Diazepam (Valium)FDA LinkGeneric 08/2021 - 09/2011
2	Antiviral Agents (Antivirals)IBA 07/2021 - 04/2016
2	phenyl-2-aminoethyl sulfide (PAES)IBA 12/2020 - 01/2018
2	HLA Antigens (Human Leukocyte Antigens)IBA 12/2020 - 05/2019
2	Clonazepam (Rivotril)FDA LinkGeneric 04/2020 - 04/2016
2	MelatoninIBA 04/2020 - 04/2019
2	Midodrine (Midon)FDA LinkGeneric 01/2020 - 09/2017
2	Celecoxib (Celebrex)FDA Link 01/2019 - 08/2006
2	Circular RNAIBA 01/2019 - 01/2018
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019 - 08/2006
2	16S Ribosomal RNAIBA 10/2018 - 11/2017
2	hydroxide ionIBA 09/2018 - 09/2017
2	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 01/2018 - 09/2017
2	AlbuminsIBA 01/2018 - 04/2016
2	Glucose (Dextrose)FDA LinkGeneric 10/2017 - 06/2013

Therapy/Procedure

30	Therapeutics 12/2021 - 07/2007
17	Immunotherapy 10/2022 - 12/2013
8	Transplantation 01/2017 - 10/2004
5	Electrodes (Electrode) 01/2015 - 03/2004
3	Aftercare (After-Treatment) 08/2021 - 09/2011
2	Anterior Temporal Lobectomy 03/2021 - 01/2008